Physician profile
Kaymie M Johnston
NPI 1679751069
$1,040.07
in general payments reported to CMS, 2019-2025
10 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $400 · 2023: $269 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Products, LP | $223.99 | 2022 | |
| Gilead Sciences, INC. | $216.36 | 2022-2023 | |
| Viiv Healthcare Company | $159.90 | 2023 | Apretude, Cabenuva, Dovato |
| La Jolla Pharmaceutical Company | $128.15 | 2025 | Giapreza, Xacduro, Zevtera |
| Insmed, INC. | $115.89 | 2021 | |
| Shionogi INC | $111.35 | 2025 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2022 | |
| Merck Sharp & Dohme LLC | $23.21 | 2023 | Gardasil 9 |
| Hologic Sales and Service, LLC | $17.01 | 2022 | |
| Hologic INC | $15.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaymie Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.